| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(10)62353-7 |
| P698 | PubMed publication ID | 21497898 |
| P50 | author | Julio Montaner | Q1712378 |
| Evan Wood | Q85344858 | ||
| Brandon DL Marshall | Q60058726 | ||
| Thomas Kerr | Q85344273 | ||
| P2093 | author name string | M-J Milloy | |
| P2860 | cites work | Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users | Q24558770 |
| Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility | Q24649575 | ||
| Summary of findings from the evaluation of a pilot medically supervised safer injecting facility | Q24673390 | ||
| Accuracy of city postal code coordinates as a proxy for location of residence | Q24806381 | ||
| The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility | Q28283787 | ||
| Release from prison--a high risk of death for former inmates | Q33717788 | ||
| Mechanisms of fatal opioid overdose | Q33856907 | ||
| Ambient temperature and risk of death from accidental drug overdose in New York City, 1990-2006 | Q33969506 | ||
| Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study | Q34315641 | ||
| Needle exchange is not enough: lessons from the Vancouver injecting drug use study | Q34432600 | ||
| Safer injection facility use and syringe sharing in injection drug users. | Q34559436 | ||
| Heroin overdose: research and evidence-based intervention | Q35147553 | ||
| Drug consumption facilities: an update since 2000. | Q35173220 | ||
| Racial/ethnic disparities in overdose mortality trends in New York City, 1990-1998. | Q36273553 | ||
| Modelling crack cocaine use trends over 10 years in a Canadian setting. | Q36277065 | ||
| Attendance, drug use patterns, and referrals made from North America's first supervised injection facility | Q36342901 | ||
| Comparing alternative approaches to measuring the geographical accessibility of urban health services: Distance types and aggregation-error issues | Q36492267 | ||
| Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors | Q37114061 | ||
| Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study. | Q37224938 | ||
| Circumstances and witness characteristics associated with overdose fatality | Q37390705 | ||
| Elevated overdose mortality rates among First Nations individuals in a Canadian setting: a population-based analysis | Q37786349 | ||
| Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS). | Q38390784 | ||
| Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. | Q38473638 | ||
| Drug-related overdose deaths in British Columbia and Ontario, 1992-2004. | Q39775956 | ||
| It's time for Canadian community early warning systems for illicit drug overdoses | Q39791694 | ||
| Factors associated with geographic migration among a cohort of injection drug users | Q39843049 | ||
| Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility | Q39850170 | ||
| Public injection settings in Vancouver: physical environment, social context and risk | Q40185034 | ||
| Do supervised injecting facilities attract higher-risk injection drug users? | Q40406969 | ||
| Mechanism of cocaine-induced hyperthermia in humans | Q40581210 | ||
| Drastic elevations in mortality among female injection drug users in a Canadian setting | Q42675244 | ||
| Longitudinal Patterns of Drug Injection Behavior in the ALIVE Study Cohort,1988-2000: Description and Determinants | Q44595129 | ||
| Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia | Q45060409 | ||
| Supervised injecting facilities: time for scale-up? | Q45393966 | ||
| Changes in Canadian heroin supply coinciding with the Australian heroin shortage. | Q50781430 | ||
| The quantification of mortality resulting from the regular use of illicit opiates. | Q52277271 | ||
| Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. | Q52289027 | ||
| An R-squared measure of goodness of fit for some common nonlinear regression models | Q56505613 | ||
| Rationale for evaluating North America's first medically supervised safer-injecting facility | Q57671841 | ||
| Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia | Q57690350 | ||
| Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility | Q57690463 | ||
| Injection drug users' perceptions regarding use of a medically supervised safer injecting facility | Q57690524 | ||
| Attendance at Supervised Injecting Facilities and Use of Detoxification Services | Q57690584 | ||
| Drug-related overdoses within a medically supervised safer injection facility | Q57690614 | ||
| Being realistic about benefits of supervised injecting facilities | Q59546244 | ||
| P433 | issue | 9775 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug overdose | Q3505252 |
| P304 | page(s) | 1429-1437 | |
| P577 | publication date | 2011-04-15 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study | |
| P478 | volume | 377 |
| Q37274997 | "People knew they could come here to get help": an ethnographic study of assisted injection practices at a peer-run 'unsanctioned' supervised drug consumption room in a Canadian setting |
| Q35744236 | "We need somewhere to smoke crack": An ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada |
| Q37552432 | 'It's more about the heroin': injection drug users' response to an overdose warning campaign in a Canadian setting. |
| Q34611579 | A cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada. |
| Q34009387 | A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada |
| Q47319936 | A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013. |
| Q37322084 | A cross-sectional national survey assessing self-reported drug intake behavior, contact with the primary sector and drug treatment among service users of Danish drug consumption rooms |
| Q34461322 | A cross-sectional study of public attitudes towards safer drug use practices in British Columbia, Canada |
| Q41993740 | A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015 |
| Q37010947 | A qualitative study of how Danish drug consumption rooms influence health and well-being among people who use drugs |
| Q33910606 | Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City |
| Q93018582 | Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia |
| Q90194887 | Addressing overdose risk among unstably housed women in San Francisco, California: an examination of potential fentanyl contamination of multiple substances |
| Q37184992 | Alternate Routes of Administration among Prescription Opioid Misusers and Associations with Sexual HIV Transmission Risk Behaviors |
| Q37431912 | An integrated approach to care attracts people living with HIV who use illicit drugs in an urban centre with a concentrated HIV epidemic |
| Q50760330 | Canada moving backwards on illegal drugs. |
| Q57815349 | Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada |
| Q89837130 | Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting |
| Q89587729 | City checking: Piloting the UK's first community-based drug safety testing (drug checking) service in 2 city centres |
| Q34001233 | Cohort profile: Seek and treat for the optimal prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC) |
| Q44334478 | Commentary on Bruneau et al. (2012): injection of prescription opioid pain relievers and infectious disease risk |
| Q40351462 | Commentary on Enns et al. (2016): Supervised injection facilities as a cost-effective intervention |
| Q42646832 | Contextual factors associated with rushed injecting among people who inject drugs in Thailand |
| Q36175183 | Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study |
| Q92055233 | Court as a health intervention to advance Canada's achievement of the sustainable development goals : a multi-pronged analysis of Vancouver's Downtown Community Court |
| Q47105776 | Does evidence support supervised injection sites? |
| Q37638349 | Drug use in business bathrooms: An exploratory study of manager encounters in New York City |
| Q90592568 | Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs |
| Q40055225 | Emergency Department-based Opioid Harm Reduction: Moving Physicians From Willing to Doing |
| Q90599877 | Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale |
| Q41193164 | Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs. |
| Q89451350 | Expanding supervised injection facilities across Canada: lessons from the Vancouver experience |
| Q47163239 | Exploring the role of an unsanctioned, supervised peer driven injection facility in reducing HIV and hepatitis C infections in people that require assistance during injection. |
| Q90107371 | Factors Associated with the Use of Supervised Consumption Facilities among Women Who Inject Drugs in a Canadian Setting |
| Q91590551 | Factors associated with willingness to wear an electronic overdose detection device |
| Q44257014 | Fentanyl in the US heroin supply: A rapidly changing risk environment. |
| Q41750205 | Filtration of crushed tablet suspensions has potential to reduce infection incidence in people who inject drugs. |
| Q53525015 | Fix rooms could prevent infection in addicts. |
| Q43766203 | HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality |
| Q37009231 | HIV infection among people who inject drugs: the challenge of racial/ethnic disparities |
| Q35898498 | HIV infection and risk of overdose: a systematic review and meta-analysis |
| Q41304867 | HIV prevention and treatment strategies can help address the overdose crisis |
| Q37154709 | Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities. |
| Q92195183 | Hepatitis C virus elimination: time for disruptive innovation |
| Q47169620 | Housing and overdose: an opportunity for the scale-up of overdose prevention interventions? |
| Q64117950 | Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol |
| Q35896342 | Improving community health and safety in Canada through evidence-based policies on illegal drugs. |
| Q36089748 | Increases in the availability of prescribed opioids in a Canadian setting |
| Q42228767 | Increasing public support for supervised injection facilities in Ontario, Canada. |
| Q35066810 | Injecting drug users and their health seeking behavior: a cross-sectional study in dhaka, bangladesh |
| Q40668892 | Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study |
| Q33717043 | Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility |
| Q60912581 | Mobile supervised consumption services in Rural British Columbia: lessons learned |
| Q35999028 | Mortality from treatable illnesses in marginally housed adults: a prospective cohort study. |
| Q41196377 | Multiply disadvantaged: Health and service utilisation factors faced by homeless injecting drug consumers in Australia |
| Q38661227 | Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic |
| Q33651129 | Negotiating place and gendered violence in Canada's largest open drug scene |
| Q39848406 | No association between HIV status and risk of non-fatal overdose among people who inject drugs in Vancouver, Canada |
| Q38621000 | Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico. |
| Q89203281 | Nontraditional Alcohol and Opioid Agonist Treatment Interventions |
| Q34735099 | Ongoing impact of HIV infection on mortality among people who inject drugs despite free antiretroviral therapy |
| Q57785593 | Opinion of health professionals and drug users before the forthcoming opening of the first drug consumption room in Paris: a quantitative cross-sectional study |
| Q88646759 | Opioid Use Among Those Who Have Criminal Justice Experience: Harm Reduction Strategies to Lessen HIV Risk |
| Q28397248 | Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis |
| Q37140446 | Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist. |
| Q59444008 | Overdose deaths and Vancouver's supervised injection facility – Authors' reply |
| Q55055529 | Overdose deaths and Vancouver's supervised injection facility. |
| Q57802976 | Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program |
| Q60916860 | Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study |
| Q57803159 | Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration |
| Q39667940 | Police perceptions of supervised consumption sites (SCSs): a qualitative study |
| Q40891018 | Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada |
| Q64113306 | Potential use of supervised injection services among people who inject drugs in a remote and mid-size Canadian setting |
| Q46696473 | Preventing HIV and Hepatitis Infections Among People Who Inject Drugs: Leveraging an Indiana Outbreak Response to Break the Impasse |
| Q45130692 | Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making |
| Q50217902 | Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review |
| Q30377895 | Public health and international drug policy. |
| Q36565738 | Public opinions about supervised smoking facilities for crack cocaine and other stimulants |
| Q36202226 | Risk environments facing potential users of a supervised injection site in Ottawa, Canada |
| Q33707925 | Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention |
| Q37282087 | Risk factors for progression to regular injection drug use among street-involved youth in a Canadian setting |
| Q36041992 | Risky and rushed public crack cocaine smoking: the potential for supervised inhalation facilities |
| Q83881049 | Safe injection facilities save lives |
| Q34484766 | Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark |
| Q36663552 | Sex-Based Differences in Rates, Causes, and Predictors of Death Among Injection Drug Users in Vancouver, Canada |
| Q36691255 | Should North America's first and only supervised injection facility (InSite) be expanded in British Columbia, Canada? |
| Q90218948 | Social and structural factors associated with substance use within the support network of adults living in precarious housing in a socially marginalized neighborhood of Vancouver, Canada |
| Q30234420 | Supervised injection facilities in Canada: past, present, and future |
| Q90568818 | Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: A gender-based analysis |
| Q57092857 | Syringe sharing among people who inject drugs in London, Canada |
| Q38960176 | The Hotel Study-Clinical and Health Service Effectiveness in a Cohort of Homeless or Marginally Housed Persons |
| Q34582040 | The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort study |
| Q37164972 | The role of depression and social support in non-fatal drug overdose among a cohort of injection drug users in a Canadian setting |
| Q41949791 | The willingness of people who inject drugs in Boston to use a supervised injection facility |
| Q38817024 | Treating Addictions: Harm Reduction in Clinical Care and Prevention |
| Q47561425 | Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities |
| Q37117193 | Treatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV. |
| Q64996442 | Trends in Black and White Opioid Mortality in the United States, 1979-2015. |
| Q34403782 | Use of a medically supervised injection facility among street youth |
| Q45069794 | Use of on-site detoxification services co-located with a supervised injection facility |
| Q35547500 | Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs |
| Q37655493 | Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study |
| Q26785445 | Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature |
Search more.